| Characteristic | Novel chemical + new MOA | Novel chemical + old MOA | Repurposed or reformulated |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Region
United States
Survey time period
as of September 2018
Special properties
84 programs in type 2 diabetes clinical pipeline
Supplementary notes
NDA/BLA = New drug application/biologic license application approvals
MOA = mechanism of action
Citation formats









